|
1
|
Al Saleh S, Sharaf LH and Luqmani YA:
Signalling pathways involved in endocrine resistance in breast
cancer and associations with epithelial to mesenchymal transition
(Review). Int J Oncol. 38:1197–1217. 2011.PubMed/NCBI
|
|
2
|
Luqmani YA, Al Azmi A, Al Bader M, Abraham
G and El Zawahri M: Modification of gene expression induced by
siRNA targeting of estrogen receptor alpha in MCF7 human breast
cancer cells. Int J Oncol. 34:231–242. 2009.
|
|
3
|
Al Saleh S, Al Mulla F and Luqmani YA:
Estrogen receptor silencing induces epithelial to mesenchymal
transition in human breast cancer cells. PLoS One. 6:212011.
View Article : Google Scholar
|
|
4
|
Roxanis I: Occurrence and significance of
epithelial-mesenchymal transition in breast cancer. J Clin Pathol.
66:517–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giuliano M, Schifp R, Osborne CK and
Trivedi MV: Biological mechanisms and clinical implications of
endocrine resistance in breast cancer. Breast. 9776:70293–70294.
2011.
|
|
6
|
Khajah MA, Al Saleh S, Mathew PM and
Luqmani YA: Differential effect of growth factors on invasion and
proliferation of endocrine resistant breast cancer cells. PLoS One.
7:302012. View Article : Google Scholar
|
|
7
|
Vaupel P, Kallinowski F and Okunieff P:
Blood flow, oxygen and nutrient supply, and metabolic
microenvironment of human tumors: a review. Cancer Res.
49:6449–6465. 1989.PubMed/NCBI
|
|
8
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hashim AI, Zhang X, Wojtkowiak JW,
Martinez GV and Gillies RJ: Imaging pH and metastasis. NMR Biomed.
24:582–591. 2011.PubMed/NCBI
|
|
10
|
Cairns R, Papandreou I and Denko N:
Overcoming physiologic barriers to cancer treatment by molecularly
targeting the tumor microenvironment. Mol Cancer Res. 4:61–70.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Izumi H, Torigoe T, Ishiguchi H, et al:
Cellular pH regulators: potentially promising molecular targets for
cancer chemotherapy. Cancer Treat Rev. 29:541–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boedtkjer E, Moreira JM, Mele M, et al:
Contribution of Na+, HCO3(−)-cotransport to
cellular pH control in human breast cancer: a role for the breast
cancer susceptibility locus NBCn1 (SLC4A7). Int J Cancer.
132:1288–1299. 2013. View Article : Google Scholar
|
|
13
|
Abaza M and Luqmani YA: The influence of
pH and hypoxia on tumor metastasis. Expert Rev Anticancer Ther.
13:1229–1242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rozhin J, Sameni M, Ziegler G and Sloane
BF: Pericellular pH affects distribution and secretion of cathepsin
B in malignant cells. Cancer Res. 54:6517–6525. 1994.PubMed/NCBI
|
|
15
|
Brisson L, Reshkin SJ, Gore J and Roger S:
pH regulators in invadosomal functioning: proton delivery for
matrix tasting. Eur J Cell Biol. 91:847–860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao H, Li TK, Yang JM and Liu LF: Acidic
pH induces topoisomerase II-mediated DNA damage. Proc Natl Acad Sci
USA. 100:5205–5210. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morita T, Nagaki T, Fukuda I and Okumura
K: Clastogenicity of low pH to various cultured mammalian cells.
Mutat Res. 268:297–305. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsubara T, Diresta GR, Kakunaga S, Li D
and Healey JH: Additive influence of extracellular pH, oxygen
tension, and pressure on invasiveness and survival of human
osteosarcoma cells. Front Oncol. 3:20132013. View Article : Google Scholar
|
|
19
|
Raghunand N, Altbach MI, van Sluis R, et
al: Plasmalemmal pH-gradients in drug-sensitive and drug-resistant
MCF-7 human breast carcinoma xenografts measured by 31P magnetic
resonance spectroscopy. Biochem Pharmacol. 57:309–312. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Robey IF, Baggett BK, Kirkpatrick ND, et
al: Bicarbonate increases tumor pH and inhibits spontaneous
metastases. Cancer Res. 69:2260–2268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ibrahim-Hashim A, Cornnell HH, Abrahams D,
et al: Systemic buffers inhibit carcinogenesis in TRAMP mice. J
Urol. 188:624–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morimura T, Fujita K, Akita M, Nagashima M
and Satomi A: The proton pump inhibitor inhibits cell growth and
induces apoptosis in human hepatoblastoma. Pediatr Surg Int.
24:1087–1094. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kastelein F, Spaander MC, Steyerberg EW,
et al: Proton pump inhibitors reduce the risk of neoplastic
progression in patients with Barrett’s esophagus. Clin
Gastroenterol Hepatol. 11:382–388. 2013. View Article : Google Scholar
|
|
24
|
Williams AC, Collard TJ and Paraskeva C:
An acidic environment leads to p53 dependent induction of apoptosis
in human adenoma and carcinoma cell lines: implications for clonal
selection during colorectal carcinogenesis. Oncogene. 18:3199–3204.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Putney LK and Barber DL: Na-H
exchange-dependent increase in intracellular pH times G2/M entry
and transition. J Biol Chem. 278:44645–44649. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohtsubo T, Wang X, Takahashi A, et al:
p53-dependent induction of WAF1 by a low-pH culture condition in
human glioblastoma cells. Cancer Res. 57:3910–3913. 1997.PubMed/NCBI
|
|
27
|
Smallbone K, Maini PK and Gatenby RA:
Episodic, transient systemic acidosis delays evolution of the
malignant phenotype: Possible mechanism for cancer prevention by
increased physical activity. Biol Direct. 5:1745–6150. 2010.
View Article : Google Scholar
|
|
28
|
Chen JL, Lucas JE, Schroeder T, et al: The
genomic analysis of lactic acidosis and acidosis response in human
cancers. PLoS Genet. 4:52008. View Article : Google Scholar
|
|
29
|
Khajah MA, Almohri I, Mathew PM and
Luqmani YA: Extracellular alkaline pH leads to increased metastatic
potential of estrogen receptor silenced endocrine resistant breast
cancer cells. PLoS One. 8:20132013. View Article : Google Scholar
|
|
30
|
Calorini L, Peppicelli S and Bianchini F:
Extracellular acidity as favouring factor of tumor progression and
metastatic dissemination. Exp Oncol. 34:79–84. 2012.PubMed/NCBI
|
|
31
|
McCarty MF and Whitaker J: Manipulating
tumor acidification as a cancer treatment strategy. Altern Med Rev.
15:264–272. 2010.PubMed/NCBI
|
|
32
|
Kato Y, Nakayama Y, Umeda M and Miyazaki
K: Induction of 103-kDa gelatinase/type IV collagenase by acidic
culture conditions in mouse metastatic melanoma cell lines. J Biol
Chem. 267:11424–11430. 1992.PubMed/NCBI
|
|
33
|
Rofstad EK, Mathiesen B, Kindem K and
Galappathi K: Acidic extracellular pH promotes experimental
metastasis of human melanoma cells in athymic nude mice. Cancer
Res. 66:6699–6707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
el-Deiry WS, Tokino T, Velculescu VE, et
al: WAF1, a potential mediator of p53 tumor suppression. Cell.
75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Noda A, Ning Y, Venable SF, Pereira-Smith
OM and Smith JR: Cloning of senescent cell-derived inhibitors of
DNA synthesis using an expression screen. Exp Cell Res. 211:90–98.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Majima HJ, Oberley TD, Furukawa K, et al:
Prevention of mitochondrial injury by manganese superoxide
dismutase reveals a primary mechanism for alkaline-induced cell
death. J Biol Chem. 273:8217–8224. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Trinkaus JP: Surface activity and
locomotion of Fundulus deep cells during blastula and gastrula
stages. Dev Biol. 30:69–103. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bergert M, Chandradoss SD, Desai RA and
Paluch E: Cell mechanics control rapid transitions between blebs
and lamellipodia during migration. Proc Natl Acad Sci USA.
109:14434–14439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Norman LL, Brugues J, Sengupta K, Sens P
and Aranda-Espinoza H: Cell blebbing and membrane area homeostasis
in spreading and retracting cells. Biophys J. 99:1726–1733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fishkind DJ, Cao LG and Wang YL:
Microinjection of the catalytic fragment of myosin light chain
kinase into dividing cells: effects on mitosis and cytokinesis. J
Cell Biol. 114:967–975. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Boss J: Mitosis in cultures of newt
tissues. IV The cell surface in late anaphase and the movements of
ribonucleoprotein. Exp Cell Res. 8:181–187. 1955. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Boss J: Mitosis in cultures of newt
tissues. III Cleavage and chromosome movements in anaphase. Exp
Cell Res. 7:443–456. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Boss J: Mitosis in cultures of newt
tissues. I A critical study of the methods and material. Exp Cell
Res. 7:215–231. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Moes MJ, Bijvelt JJ and Boonstra J:
Attachment of HeLa cells during early G1 phase. Histochem Cell
Biol. 136:399–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Charras G and Paluch E: Blebs lead the
way: how to migrate without lamellipodia. Nat Rev Mol Cell Biol.
9:730–736. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Charras GT: A short history of blebbing. J
Microsc. 231:466–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wyllie AH, Kerr JF and Currie AR: Cell
death: the significance of apoptosis. Int Rev Cytol. 68:251–306.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Earnshaw WC: Nuclear changes in apoptosis.
Curr Opin Cell Biol. 7:337–343. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jacobson MD, Weil M and Raff MC:
Programmed cell death in animal development. Cell. 88:347–354.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mills JC, Stone NL, Erhardt J and Pittman
RN: Apoptotic membrane blebbing is regulated by myosin light chain
phosphorylation. J Cell Biol. 140:627–636. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bovellan M, Fritzsche M, Stevens C and
Charras G: Death-associated protein kinase (DAPK) and signal
transduction: blebbing in programmed cell death. FEBS J. 277:58–65.
2010. View Article : Google Scholar
|
|
53
|
Cotter TG, Lennon SV, Glynn JM and Green
DR: Microfilament-disrupting agents prevent the formation of
apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res.
52:997–1005. 1992.PubMed/NCBI
|
|
54
|
Cunningham CC: Actin polymerization and
intracellular solvent flow in cell surface blebbing. J Cell Biol.
129:1589–1599. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Laster SM and Mackenzie JM Jr: Bleb
formation and F-actin distribution during mitosis and tumor
necrosis factor-induced apoptosis. Microsc Res Tech. 34:272–280.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pitzer F, Dantes A, Fuchs T, Baumeister W
and Amsterdam A: Removal of proteasomes from the nucleus and their
accumulation in apoptotic blebs during programmed cell death. FEBS
Lett. 394:47–50. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vemuri GS, Zhang J, Huang R, Keen JH and
Rittenhouse SE: Thrombin stimulates wortmannin-inhibitable
phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells.
Biochem J. 314:805–810. 1996.PubMed/NCBI
|
|
58
|
Keller H and Eggli P: Protrusive activity,
cytoplasmic compartmentalization, and restriction rings in
locomoting blebbing Walker carcinosarcoma cells are related to
detachment of cortical actin from the plasma membrane. Cell Motil
Cytoskeleton. 41:181–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kohama K, Ye LH, Hayakawa K and Okagaki T:
Myosin light chain kinase: an actin-binding protein that regulates
an ATP-dependent interaction with myosin. Trends Pharmacol Sci.
17:284–287. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gallagher PJ, Herring BP and Stull JT:
Myosin light chain kinases. J Muscle Res Cell Motil. 18:1–16. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ridley AJ and Hall A: The small
GTP-binding protein rho regulates the assembly of focal adhesions
and actin stress fibers in response to growth factors. Cell.
70:389–399. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chrzanowska-Wodnicka M and Burridge K:
Rho-stimulated contractility drives the formation of stress fibers
and focal adhesions. J Cell Biol. 133:1403–1415. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jia Z, Vadnais J, Lu ML, Noel J and Nabi
IR: Rho/ROCK-dependent pseudopodial protrusion and cellular
blebbing are regulated by p38 MAPK in tumour cells exhibiting
autocrine c-Met activation. Biol Cell. 98:337–351. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fackler OT and Grosse R: Cell motility
through plasma membrane blebbing. J Cell Biol. 181:879–884. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Keller HU and Cottier H: Crawling-like
movements and polarisation in non-adherent leucocytes. Cell Biol
Int Rep. 5:3–7. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Johnson KE: Circus movements and blebbing
locomotion in dissociated embryonic cells of an amphibian, Xenopus
laevis. J Cell Sci. 22:575–583. 1976.PubMed/NCBI
|
|
67
|
Haston WS and Shields JM: Contraction
waves in lymphocyte locomotion. J Cell Sci. 68:227–241.
1984.PubMed/NCBI
|
|
68
|
Grinnell F: Migration of human neutrophils
in hydrated collagen lattices. J Cell Sci. 58:95–108.
1982.PubMed/NCBI
|
|
69
|
Keller HU, Naef A and Zimmermann A:
Effects of colchicine, vinblastine and nocodazole on polarity,
motility, chemotaxis and cAMP levels of human polymorphonuclear
leukocytes. Exp Cell Res. 153:173–185. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Keller HU and Zimmermann A: Shape changes
and chemokinesis of Walker 256 carcinosarcoma cells in response to
colchicine, vinblastine, nocodazole and taxol. Invasion Metastasis.
6:33–43. 1986.PubMed/NCBI
|
|
71
|
Zatulovskiy E, Tyson R, Bretschneider T
and Kay RR: Bleb-driven chemotaxis of Dictyostelium cells. J Cell
Biol. 204:1027–1044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Pankova K, Rosel D, Novotny M and Brabek
J: The molecular mechanisms of transition between mesenchymal and
amoeboid invasiveness in tumor cells. Cell Mol Life Sci. 67:63–71.
2010. View Article : Google Scholar :
|
|
73
|
Mandeville JT, Lawson MA and Maxfield FR:
Dynamic imaging of neutrophil migration in three dimensions:
mechanical interactions between cells and matrix. J Leukoc Biol.
61:188–200. 1997.PubMed/NCBI
|
|
74
|
Friedl P, Borgmann S and Brocker EB:
Amoeboid leukocyte crawling through extracellular matrix: lessons
from the Dictyostelium paradigm of cell movement. J Leukoc Biol.
70:491–509. 2001.PubMed/NCBI
|
|
75
|
Sahai E and Marshall CJ: Differing modes
of tumour cell invasion have distinct requirements for Rho/ROCK
signalling and extracellular proteolysis. Nat Cell Biol. 5:711–719.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wolf K, Mazo I, Leung H, et al:
Compensation mechanism in tumor cell migration:
mesenchymal-amoeboid transition after blocking of pericellular
proteolysis. J Cell Biol. 160:267–277. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wyckoff JB, Pinner SE, Gschmeissner S,
Condeelis JS and Sahai E: ROCK- and myosin-dependent matrix
deformation enables protease-independent tumor-cell invasion in
vivo. Curr Biol. 16:1515–1523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Rosel D, Brabek J, Tolde O, et al:
Up-regulation of Rho/ROCK signaling in sarcoma cells drives
invasion and increased generation of protrusive forces. Mol Cancer
Res. 6:1410–1420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Torgerson RR and McNiven MA: The
actin-myosin cytoskeleton mediates reversible agonist-induced
membrane blebbing. J Cell Sci. 111:2911–2922. 1998.PubMed/NCBI
|
